AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31

AMARIN CORP PLC\UK

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026

$11.53+0.21 (+1.86%)

Close on Oct 19, 2026

Market cap: $4.80B
P/E (TTM): –
Dividend yield: –

AMARIN CORP PLC\UK balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31
Cash & Equivalents	135	121	199	218	219	187	645	249	74	99	107	120	192	260	117	31	52	14
Short-Term Investments	168	173	121	92	235	314	–	–	–	–	–	–	–	–	–	–	–	–
Cash & Short-Term Investments	303	294	321	309	454	501	645	249	74	99	107	120	192	260	117	31	52	14
Receivables	127	122	134	131	164	155	116	67	45	20	14	7.84	3.65	–	–	–	–	–
Inventory	196	166	259	229	235	189	77	58	30	21	19	14	21	21	–	–	–	–
Prepaid Expenses & Other	24	13	12	19	22	31	13	2.95	3.46	6.98	3.15	2.63	–	–	1.84	0.71	–	–
Other Current Assets	–	–	–	–	–	–	–	–	–	–	–	2.63	1.56	3.25	1.84	1.06	–	–
Total Current Assets	650	595	725	689	879	879	855	378	153	146	144	145	219	286	119	33	–	–
Property, Plant & Equipment	0.01	0.02	0.11	0.87	1.43	2.02	2.36	0.06	0.03	0.08	0.24	0.38	0.58	0.81	0.43	0.09	–	–
Gross Property, Plant & Equipment	1.49	1.49	1.49	3.35	3.35	3.63	3.38	0.90	0.84	0.82	1.00	0.97	0.97	1.10	0.32	0.20	–	–
Accumulated Depreciation	-1.47	-1.47	-1.38	-2.47	-1.92	-1.62	-1.02	-0.84	-0.82	-0.76	-0.75	-0.59	-0.39	-0.36	-0.18	-0.12	–	–
Construction in Progress	–	–	–	–	–	–	–	–	–	0.01	–	0	0	0.07	0.29	–	–	–
Long-Term Investments	–	–	–	1.28	35	62	–	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Right-of-Use Assets	6.46	7.59	8.31	9.07	7.66	8.05	8.51	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	13	16	19	22	24	14	15	7.48	8.13	8.77	9.42	10	11	11	–	–	–	–
Deferred Tax Assets	–	–	–	–	–	–	–	–	0	11	20	13	12	8.04	4.73	2.17	–	–
Other Long-Term Assets	1.07	1.21	1.36	0.46	0.46	0.43	1.07	0.17	0.17	0.74	0.17	2.83	4.36	4.95	2.24	2.17	–	–
Total Assets	671	685	832	886	1,068	966	882	386	162	167	173	171	252	311	126	35	–	–
Accounts Payable	45	40	53	65	115	106	50	38	25	6.06	11	8.53	6.38	17	4.42	4.45	–	–
Current Portion of Long-Term Debt	–	–	–	–	0	0	50	34	22	16	12	15	13	–	–	–	–	–
Current Debt	–	–	–	–	0	0	50	34	22	16	12	15	13	–	–	–	–	–
Current Portion of Leases	2.15	1.95	1.87	1.57	–	1.48	–	–	–	–	–	–	–	–	–	–	–	–
Current Income Taxes Payable	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.59	–	–
Deferred Revenue (Current)	–	–	2.34	2.20	2.65	2.93	2.34	1.22	1.64	1.17	0.92	0	1.70	–	–	–	–	–
Other Current Liabilities	18	18	23	36	46	29	17	7.71	5.16	5.80	4.28	2.25	3.34	3.16	1.78	0.57	–	–
Total Current Liabilities	194	180	259	259	371	307	242	157	109	76	51	40	38	25	8.45	7.58	–	–
Long-Term Debt	–	–	–	–	–	–	–	46	71	85	92	90	88	85	0.76	0.09	–	–
Long-Term Leases	6.08	7.72	8.74	10	8.58	9.15	9.44	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	8.20	9.70	11	12	10	11	9.80	–	–	–	–	–	–	–	–	–	–	–
Other Long-Term Liabilities	11	12	9.06	8.21	7.65	6.21	3.75	11	1.15	0.71	0.34	0.39	0.66	0.82	0.76	–	–	–
Total Liabilities	211	199	280	291	401	339	274	233	227	176	301	260	286	315	132	238	–	–
Total Debt	–	–	–	–	0	0	50	80	93	101	104	105	101	85	0.76	0.09	–	–
Preferred Stock	–	–	–	–	–	–	22	22	24	24	24	–	–	–	–	–	–	–
Common Stock	310	305	303	299	294	290	269	247	209	207	150	143	141	125	113	90	–	–
Additional Paid-In Capital	1,924	1,915	1,899	1,885	1,855	1,818	1,764	1,283	978	965	816	739	739	619	449	207	–	–
Retained Earnings	-1,707	-1,669	-1,586	-1,527	-1,421	-1,429	-1,411	-1,389	-1,272	-1,204	-1,118	-970	-914	-748	-568	-499	–	–
Treasury Stock	-67	-65	-64	-62	-61	-51	-36	-10	-4.23	-1.50	-0.41	-0.22	-0.22	-0.22	-0.22	-0.22	–	–
Shareholders' Equity	459	486	552	595	667	628	608	152	-65	-9.06	-129	-88	-34	-4.00	-5.96	-202	6.60	8.42
Total Equity	459	486	552	595	667	628	608	152	-65	-9.06	-129	-88	-34	-4.00	-5.96	-202	6.60	8.42
Total Liabilities & Equity	671	685	832	886	1,068	966	882	386	162	167	173	171	252	311	126	35	–	–
Shares Outstanding(shares)	416	412	409	409	397	393	360	326	271	269	183	175	173	150	136	107	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 42.0%
Operating margin: -21.9%
Net margin: -14.6%
Return on equity, FY2025: -8.2%

Financial strength

Current ratio: 3.67
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 87.4%

Valuation

P/E ratio: –
Price to sales: 25.78
Price to book: 10.82
Dividend yield: –